You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Biochemistry & Bioanalytical
Western Blots
GD3 offers a full range of services, including protein extraction, electrophoresis, transfer, and visualization, alongside expert consultation to optimize your experimental design. Our commitment to scientific excellence and timely delivery helps accelerate your research program regardless of whether you are investigating protein expression, post-translational modifications, or biomarker validation.
Figure 1. Western blot of retinal tissue 3 days following optic nerve crush (ONC) compared to uninjured control: upregulation of injury marker, phosphorylated-cJun, demonstrates activation of signaling pathways important for neuronal outcome following ONC.
Learn more about